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Abstract
Despite successful weight loss after bariatric surgery (BS), weight regain (WR) 
may occur on long term following most bariatric procedures, with 20–30% of 
patients either failing to reach their target weight goals or failing to maintain the 
achieved weight loss. Significant WR has important health consequences, includ-
ing the reversal of the improved obesity-related comorbidities and psychological 
function leading to decreased quality of life. Given the challenges faced by these 
patients, there is a need for multidisciplinary approaches to deal with WR. This 
chapter addresses the issue of WR among bariatric patients. It starts with the vari-
ous definitions of insufficient weight loss and WR and the prevalence of weight 
regain by type of bariatric procedure. The chapter then explores the underlying 
causes as well as the predictors of WR. It will also outline the behavioral and 
psychotherapeutic, dietary and exercise strategies employed in the prevention 
of post-surgery WR. The chapter will then highlight the non-surgical and surgi-
cal approaches used in the management of WR. The chapter will conclude with 
a summary of the findings emphasizing that WR is complex and multifactorial, 
requiring multidisciplinary and multimodal dietary, behavioral, pharmacological, 
and surgical management strategies tailored to meet the individual needs of each 
patient.
Keywords: bariatric surgery, weight regain, insufficient weight loss, causes, 
predictors, management
1. Introduction
Bariatric surgery (BS) can achieve weight loss (WL), treat obesity-related 
metabolic disease and enhance the metabolic status by improving hypertension, 
type 2 diabetes mellitus (T2DM) and lipid profile, thereby decreasing the cardio-
vascular risk [1, 2]. Despite effective WL after BS, some patients do not achieve 
their target weight goals, and others regain a significant portion of their weight at 
long-term follow-up. Weight regain (WR) has a range of undesirable medical and 
psychological impacts [3, 4].
WR might occur after common BS procedures e.g. gastric bypass, adjustable 
gastric banding (LAGB), and sleeve gastrectomy (LSG), to different extents and at 
variable interval times [5]. The causes for WR are multifactorial, including patient- 
and procedure-specific factors [6, 7]. Interestingly, WR might occur despite the 
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patients’ stated adherence to advised behavioral measures and absence of surgical 
anatomic causes. This suggests that various pre or post-operative demographic, 
physiologic or metabolic features could play a role. Given the complexity of the 
factors involved in WR, multimodal management strategies tailored to meet the 
individual needs of patients are essential.
2. Definitions of insufficient weight loss and weight regain
There is a distinction between two types of WL failure post BS: insufficient WL 
(IWL); and WR. The grouping of these two categories together should be discour-
aged. IWL is defined as excess weight loss (EWL%) of <50% at 18 months after BS 
[8], while WR is defined as regain of weight that occurs after achievement of an 
initial successful weight loss (defined as EWL% > 50%).
A range of definitions describe WR post BS [9, 10]. The lack of standard defini-
tion, consensus statements and guidelines leads to poor reporting and understand-
ing of the significance of WR [3, 8, 10]. Moreover, clearer definitions will help to 
recognize when intervention is required and guide the intervention [8]. Available 
definitions include: regaining weight reaching a body mass index (BMI) >35 after 
successful WL [11]; an increase in BMI of ≥5 kg/m2 above the nadir weight [12]; > 
25% EWL% regain from nadir [13, 14]; increase in weight of >10 kg from nadir [15, 
16]; any WR [17]; any WR after type 2 diabetes mellitus (T2DM) remission [18]; 
or an increase of >15% of total body weight from nadir [19, 20]. The most common 
definition, an increase of ≥10 kg of nadir weight [15, 21], does little to define the 
clinical significance of the amount of WR in the affected individual. Therefore, a 
WR definition needs to be meaningful rather than arbitrary. It is important to note 
that multiple definitions affect the reporting of the prevalence of WR, and consid-
erably change the reported outcomes. For instance, applying 6 different WR defini-
tions to 55 patients 5 years after LSG led to WR rates ranging from 9–91% [10]. 
Similarly, the use of 5 continuous and 8 dichotomous measures among 1406 Roux 
en Y gastric bypass (RYGB) patients followed up for 5 years resulted in WR rates 
ranging from 44–87% [9]; and others reported rates between 16–37% WR 5 years 
post LAGB, LSG, and RYGB [19]. Therefore, more research is needed to define WR 
after BS in order to standardize its measurement.
3. Prevalence of WR and IWL after bariatric procedures
WR following BS varies by the type of BS performed, whether restrictive or 
malabsorptive as outlined below.
3.1 Laparoscopic gastric band (LAGB)
A large prospective multicenter study in Sweden found that 10 years post LAGB, 
patients regained 38% of the maximal weight they lost post surgery [1]. Likewise, 
research at 10 US hospitals that assessed weight trajectories among 2348 partici-
pants including 610 LAGB patients reported 1.4% WR 3 to 7 years after surgery [22] 
(Table 1).
3.2 Laparoscopic sleeve gastrectomy (LSG)
A systematic review of 21 studies reported WR rates post LSG ranging from 
5.7% at 2 years to 76% over variable follow-up periods from (2 to 6 years) [3]. 
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Other studies found that WR started three years after LSG [23].  At 5 years, WR 
(>10 kg) was observed in 39.5% of patients, where the EWL% decreased from 
84.8% at one year to 57.3% after 5 years [23].
3.3 Roux en Y gastric bypass (RYGB)
Research among 1426 patients found that at 2 years, 17.1% regained >15% of 
their 1-year post-operative weight [24]. Others reported a 22.5% WR at 3 years and 
26.8% at 5 years [9]. The Longitudinal Assessment of Bariatric Surgery (LABS) 
study observed 3.9% WR between 3 and 7 years post RYGB [22]. Others found  that 
among 2965 patients, WR was 14.6% at 5 years post-surgery [25].
4. Causes of WR
Causes of WR following BS are multifactorial, and can be categorized into 
patient- and surgical-specific causes. The former includes hormonal causes and 
maladaptive lifestyle behaviors (e.g. dietary non-compliance and physical inactiv-
ity) [3, 7]. Other factors include the lack of follow-up support and mental health 
causes such as psychiatric conditions and maladaptive eating [3, 7]. Surgical-
specific factors include e.g., enlargement of the gastric pouch or gastro-gastric 
fistula. Recognizing such underling etiologies is key to develop appropriate manage-
ment strategies [26]. Figure 1 depicts the causes of WR.
4.1 Hormonal
Weight reduction following BS may be dependent to some extent on the ‘nor-
malization’ of hormonal inputs. Furthermore, patients who fail to achieve WL post-
BS or experience WR may have persistent hormonal ‘imbalances’ (e.g. high ghrelin, 
low peptide YY) which need to be addressed in order to accomplish WL.
Ghrelin is a hormone that is important in regulating food intake and energy 
balance. BS has a positive effect on ghrelin, where a significant decrease in both 
fasting and post prandial ghrelin is observed early after BS leading to decreased 
appetite and food intake [27]. However, research have found that among RYGB 
patients, subjects with WR had significantly higher pre and postoperative ghrelin 
levels compared to those who maintained or lost weight (722 ± 29 vs. 540 ± 156 pg/ml) 
[28]. Similarly, patients with WR 5 years post LSG had higher plasma ghrelin levels 
than their level at 1 year post surgery [16].
Type of BS Prevalence of WR
LAGB 1.4% between years 3 and 7 years [22]
38% at 10 years [1]
LSG 5.7% at 2 years [3]
39.5% at 5 years [23]
76% over variable follow-up periods ranging from 2 to 6 years [3]
RYGB 17.1% at 2 years [24]
22.5% at 3 years [9]
14.6%–26.8% at 5 years [9, 25]
3.9% between 3 and 7 years [22]
LAGB: Laparoscopic gastric band; LSG: Laparoscopic sleeve gastrectomy; RYGB: Roux en Y gastric bypass.
Table 1. 
Prevalence of WR by type of BS.
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Peptide YY (PYY) is a 36 amino acid hormone that is released by the L-cells of 
the gastrointestinal tract after food intake to suppress  appetite. Likewise, Glucagon-
like protein-1 (GLP-1) is released after meals by L cells in the small intestine to 
stimulate insulin secretion, inhibit glucagon release, and delay gastric emptying [29]. 
Both these anorexigenic hormones display enhanced nutrient-stimulated secretion 
after BS, more so after RYGB than LSG [29]. However, the level of theses hormones 
was noticed to be lower in patients with WR. For instance, meal-stimulated gastric 
inhibitory polypeptide and glucagon-like peptide-1 (GLP-1) levels at 30 min were 
lower in 10 patients who had WR compared with 14 patients who successfully main-
tained WL post RYGB [30]. Whilst hormonal adaptation as a biological response to 
non-surgical WL has been examined [31], its influence on WR post BS is less docu-
mented in humans. For example, rodent studies showed that postsurgical WR was 
associated with failure to maintain elevated plasma PYY concentrations [32].
4.2 Nutritional non-adherence
Immediately following BS, caloric intake is reduced due to a smaller gastric 
capacity, diminished hunger, and increased satiety brought about by the anatomical 
and metabolic changes. Nevertheless, for some patients, caloric intake gradually 
increases over time which contributes to postoperative WR. In the Swedish Obesity 
Study, mean daily intakes of 2900, 1500, 1700,1800, 1900, and 2000 kcal/day 
were observed at baseline, 6 months, 12 months, 2 years, 3 years, and 4–10 years 
postsurgery respectively [1]. Such increase in food intake often begins in the second 
post-operative year, likely causing WR [1]. In addition, dietary non-adherence and 
the consumption of high-calorie foods and beverages contribute to the higher caloric 
intake leading to WR. A postoperative behavioral survey of 203 patients observed 
Figure 1. 
Summary of the causes, predictors and prevention and management strategies of weight regain.
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positive correlations between the magnitude of WR and evening or night consump-
tion of large quantities of food, eating large amounts of high-fat foods, and eating 
out more frequently [33]. Equally, among 289 RYGB patients, 23% demonstrated 
dietary non-adherence and a continuation of pre-surgical eating patterns, leading to 
suboptimal weight loss and WR [34]. Such evidence substantiate the importance of 
diet quality and caloric intake as causative factors for WR after BS, and also highlight 
the importance of measuring and documenting the diet quality after BS [35].
Grazing behavior is the repeated episodes of consumption of smaller quantities 
of food over a long period of time accompanied by feelings of loss of control [36]. 
Those engaging in grazing nibbled continuously ≥2 days per week for a 6-month 
period, with an inability to stop or control their eating while nibbling [36]. Grazing 
contributes to poor weight outcomes post BS [37]. Although grazing and binge 
eating are similar as they involve subjective episodes of food consumption accompa-
nied by a loss of control; however, grazing is physiologically more possible post BS 
than large binges. In 80% of patients with preoperative binge eating or grazing with 
loss of control, these behaviors returned 6 months post-surgery [36]. This suggests 
that preoperative binge eating may reemerge as postsurgical grazing in the context 
of a reduced stomach capacity [36].
Food indiscretion also contributed to WR. For instance, the follow up of 100 
patients for 85 months after surgery revealed that poor dietary habits including con-
sumption of excessive calories, snacks, sweets oils and fatty foods were statistically 
higher in WR patients [6]. This highlightes the importance of appropriate nutritional 
counselling for long-term weight maintenance. Lack of appropriate nutritional follow-
up was also significantly associated with WR post BS [6]. For example, studies have 
found that among those with WR post-RYGB, 60% never maintained follow-up with 
appropriate nutritional consultants [38].
4.3 Physical Inactivity
Inadequate physical activity contributes to WR. Only 10–24% of BS patients 
met the guidelines regarding minimal physical activity for health promotion (i.e., 
≥150 min/week or moderate-to-vigorous physical activity in bouts of ≥10 min) [39]. A 
meta-analysis of 14 studies and a literature review of 19 studies concluded that post-BS 
physical activity was significantly associated with greater WL [40]. Amongst 100 obese 
patients post-RYGB, those who performed physical activity had the lowest incidence 
of WR compared to those who were relatively inactive [6]. Barriers to exercise among 
bariatric patients such as health concerns, lack of proximity to a gym/park, or feeling 
self-conscious should be identified and addressed [40]. Such findings highlight the 
importance of measuring and documenting physical activity levels after BS [35].
Similarly, sedentary behavior, defined as ‘any waking behavior performed while in 
a sitting or reclining posture that requires very low energy expenditure’. The represents 
a risk factor for WR Sedentary behavior is associated with increased risk of obesity and 
related comorbidities [40]. Research have found that severely obese BS candidates are 
at high risk for SB [41]. In this study they found that BS candidates spent about 30% of 
their sedentary time watching television, suggesting that this is an important cause of 
sedentary behavior and should be a target for patient counseling [41].
4.4 Mental health
Mental health status prior to surgery is linked to WL following BS. Therefore, 
pre-operative psychological evaluation is important. Psychological factors might 
interfere with successful WL by undermining motivation, diet and exercise 
compliance, and other health behaviors critical to maintaining WL [42]. Among 
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60 adults who underwent RYGB or LAGB, 40% and 33.4% had single or multiple 
psychiatric diagnoses respectively, 47.5% stopped losing weight after 1 year, and 
29.5% regained weight [43]. Furthermore, patients with ≥2 psychiatric conditions 
were 6 times more likely to either stop losing weight or regain weight relative to 
those with no or single psychiatric diagnosis [43]. Evidence supports the asso-
ciation between post-operative depressive disorders and poorer WL; however, 
the directionality of the relationship remains unknown [44]. More research is 
required to assess the long-term associations and directionality of depression and 
weight loss post BS.
4.5 Maladaptive eating: Binge eating (BE) disorder
Maladaptive eating patterns after BS have impact on weight and psychologi-
cal outcomes [45]. One of these abnormal eating patterns is BE disorder which 
is defined as ‘the consumption of large quantities of food during a short amount 
of time without being in control of this behavior’, and is strongly associated with 
psychological distress [26]. BE disorder predicts poorer weight outcomes post 
BS, resulting in smaller BMI reductions as well as more WR [46, 47]. Despite the 
physical limitations of BS on stomach capacity, BE is not always abolished and many 
of those who had BE before BS still had feelings of loss of control when eating even 
small amounts of food post BS [37, 47]. Following RYGB, patients who regained 
>10% of their EWL% had significantly higher frequencies of BE and loss of control 
[46], and these maladaptive eating behaviors were significantly correlated with 
greater WR [46]. Follow up of 96 patients post RYGB two to seven years after 
surgery showed that binge eaters increased their BMI by 5.3 kg/m2 compared with 
2.4 kg/m2 increase in non-binge eaters [48]. Likewise, among LAGB patients, the 
prevalence of eating disorder increased from 26.3% to 38.0% over one year post 
surgery, an increase that correlated with poorer WL outcomes [37].
4.6 Anatomic surgical failure
Each type of BS has its own potential mechanism/s of surgical failure that can 
lead to WR as outlined below.
4.6.1 Laparoscopic gastric band
LAGB success is correlated with appropriate follow-up, as saline adjustment 
of the band is essential for proper restriction and WL. Therefore, it is important 
to assess patients with WR after LAGB for potential pouch distension. Pouch 
distension is managed conservatively by complete band deflation, low calorie diet, 
reinforcement of portion size, and follow-up contrast study in 4–6 weeks, with 
success in more than 70% of patients [49]. On the other hand, premature removal 
of LAGB also causes WR. Studies have found that only 12% of patients with early 
band removal maintained their current weight [50]. Long term, LAGB removal rate 
is high, reaching 12% [51]. Moreover, after 14 years, the reoperation rate was as high 
as 30.5% with an average reoperation rate of 2.2% for every year of follow-up [51]. 
The main reason for LAGB removal was intolerance secondary to increased reflux 
type symptoms [52].
4.6.2 Laparoscopic sleeve gastrectomy
There are surgical causes of WR post LSG. The gastric sleeve may dilate over 
time leading to reduced restrictive effect and increase in gastric capacity, both 
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associated with reduced satiety response and increased food intake resulting in 
WR [23]. For instance, among the 15.7% patients who had WR, CT scan volumetry 
showed that the mean gastric volume increased from 120 mL early after surgery 
to a mean of 240 mL at 3 years and to 524 mL at 5 years follow-up [23]. Several 
theories have been proposed as to the relationship of increased gastric volume and 
WR. One theory is that the physiologic dilation of the remnant stomach over time 
and the size of the gastric sleeve are linearly correlated with post-operative BMI [53, 
54]. Another theory is the incomplete removal of the gastric fundus [55, 56], where 
in many cases, the dissection over the fundus, especially on the posterior aspect, 
may be difficult and technically demanding, notably in patients with the extreme 
obesity. Therefore, the success of LSG depends on the surgeon’s learning curve [55].
4.6.3 Roux-en-Y gastric bypass
RYGB produces WL through restriction of intake and malabsorption. In assess-
ing WR post-RYGB, anatomical abnormalities are proposed to play a role. Dilatation 
of the gastric pouch or gastrojejunostomy (GJ) stoma outlet have been associated 
with loss of satiety with subsequent increase in food intake and WR [57, 58]. Among 
205 RYGB patients who had upper endoscopy as workup for WR, dilation of the GJ 
was identified in 58.9%, enlarged gastric pouch in 28.8%, and both abnormalities 
in 12.3% of patients [57]. Multivariate analysis found that stoma diameter (>2 cm) 
was independently associated with WR [58], where among 28 patients following 
RYGB, WR was associated with dilated gastric stoma [59]. In this group, successful 
reduction in anastomotic size (<12 mm) with a sclerotic agent resulted in a mean 
26-kg WL at 18 months [59].
Another anatomic change that reduces RYGB’S effectiveness is gastro-gastric 
fistula, an abnormal communication between the gastric pouch and the excluded 
stomach. This is thought to develop as a result of the breakdown of the surgical 
staple line. Although gastro-gastric fistulas are uncommon, with a 1.5–6% incidence 
rate [60]. Gastro-gastric fistulas have potentially significant effects as a compli-
cation after RYGB [60] as they may diminish the restrictive and malabsorptive 
components of RYGB leading WR [61].
5. Predictors of WR post BS
Knowledge of the preoperative predictors of WR post-BS can assist in identify-
ing patients at risk for WR. The bariatric team can then offer such patients appro-
priate resources and counseling. Figure 1 depicts the predictors of WR.
5.1 Age
Age seems to be a predictor of WR, however, findings are inconsistent. Some 
smaller studies identified older age as a potential preoperative predictor of WR [62, 
63]. Among 227 patients who underwent RYGB, older age (>60 years) predicted 
inadequate EWL% at 12 months [62]. While others found that younger individuals 
were more likely to have WR after RYGB [24].
5.2 Gender
Among post RYGB patients, male sex was associated with a worse weight trajec-
tory [22] and suboptimal WL at 1 year after surgery [64]. Others found no effect of 
gender on weight loss outcomes [62].
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5.3 Duration since surgery
Longer duration after BS predicted WR [24]. One study reported significant longer 
time since RYGB surgery in patients with WR (6 years) compared with patients who 
sustained their weight loss (3.3 years) [24]. Longer durations after surgery are prob-
ably associated with resolution of food intolerances, return to preoperative eating and 
other lifestyle patterns, anatomic surgical failure, or poor attendance of postoperative 
appointments [7, 65].
5.4 Preoperative BMI
Greater preoperative BMI was significantly associated with IWL [64]. A meta-
analysis found that preoperative BMI and super-obesity were negatively associ-
ated with WL, where super-obese patients had 10.1 EWL% decrease [66]. Others 
observed that at 12 months post RYGB or LAGB, patients with baseline BMI ≥ 50 kg/
m2 were more likely to have significant WR, but those with BMI < 50 kg/m2 were 
likely to continue losing weight [67]. Similarly, 80–100% of LSG patients with pre-
surgery BMI > 40 kg/m2 had WR to BMI > 30 kg/m2 two years years after surgery; 
but only 3.6–38% of patients with lower pre-operative BMI (32.1–39.9 kg/m2) had 
BMI > 30 kg/m2 during the same time period [68].
5.5 Mental health
A presurgical BE disorder diagnosis predicted higher BMI. For example, stud-
ies found that among post-RYGB patients with 28.1 months mean follow-up, 79% 
reported WR and 15% regained ≥15% of their total weight loss [65]. The indepen-
dent predictors of significant WR were lack of control of food urges (odds ratio, 
OR = 5.1), alcohol/drug use (OR = 12.74), lowest self-reported well-being scores 
(OR = 21.5), and lack of follow-up visits [65].
5.6 Presence of Comorbidities
Presence of T2DM predicts WR [22, 62, 63]. An assessment of 2348 bariatric 
participants in the Longitudinal Assessment of Bariatric Surgery (LABS) Study 
found that low HDL cholesterol and hypertension were also associated with an 
inferior weight trajectory [22].
6. Implications of weight regain
WR has important health consequences including recurrence of obesity related 
co-morbidities such as T2DM and deterioration in quality of life (QoL), thus con-
tributing to socioeconomic and direct health care costs. This range of implications 
of WR is highlighted below.
6.1 Relapse of comorbidities
WR following BS is associated with and significantly predicted relapse of T2DM 
[12, 70]. At 10 year follow up, T2DM relapse was dependent on the extent of WR 
[70]. Patients with no WR had no relapse of their diabetes [70]. While, patients 
with mild regain (increase body weight > 5 kg from nadir) and severe regain (> 
10 kg from nadir) had 5% and 17% relapse rates respectively [70]. Among 1406 
RYGB patients with WR during the first year after reaching nadir weight, 25.8% and 
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46.2% of participants experienced progression of hyperlipidemia and hypertension 
respectively [9].
6.2 Quality of life
WR is significantly associated with deterioration in QoL [3, 9]. A study found 
that WR at 5 years after LSG was associated with a lower odds of satisfaction with 
surgery as measured by the Bariatric Analysis Reporting Outcome System (BAROS) 
score (incorporates weight loss, changes in medical conditions, health-related QoL, 
and reoperations) [3]. Others reported declines of physical and mental health–related 
QoL among 20.2% and 27.7% of patients with WR respectively [9]. Moreover, satis-
faction with surgery also declined among 12.4% of patients with WR [9]. This decline 
was observed when the rate of WR was the highest, supporting a dose–response 
relationship (i.e., the less WR, the better) for physical health–related QoL [9].
7. Prevention of weight regain
Figure 1 summarizes the prevention strategies of WR. The foundation of preven-
tion of WR after BS is aggressive behavioral interventions, similar to those utilized 
for medical weight management patients [33]. Behavioral modification components 
include commitment to regular structured physical activity, dietary control, nutri-
tional optimization with substantive changes in eating practices and lifestyle habits 
[33, 71]. Other modulators include stress management, realistic goal setting, environ-
mental control strategies, support systems, and cognitive restructuring [33, 71]. Close 
regular follow-up should start shortly after BS to reinforce nutritional and lifestyle 
instructions provided at discharge. Monitoring, education, and support should 
continue on the long term as the effectiveness of behavioral changes diminishes with 
time [33]. Self-monitoring with regular weight measurement, food records, and 
exercise diaries are essential tools for avoiding WR. These strategies increase patient’s 
awareness of eating patterns, and allow the bariatric dietitian to identify high-risk 
areas, such as nutritional inadequacy, food intolerances, poor food choices, or food 
dislikes that compromise weight loss and nutritional status [72]. In-person dietary 
counseling by a registered dietitian has an important role in prevention of WR post BS 
[73]. Structured physical activity is vital for weight prevention. An RCT demonstrated 
that a 5-month supervised exercise program post LSG resulted in reduction total body 
weight (TBW) and waist circumference with an increase in EWL% compared with the 
control group [74]. Conversely, stopping of the exercise program led to weight regain, 
with increased fat mass and decreased EWL% [74].
8. Management of WR
Figure 1 illustrates the management strategies of WR. WR after BS is complex 
and multifactorial [7]. Hence, management requires a holistic strategy addressing 
patient- and surgery-related factors that might contribute to WR. Dietary patterns, 
psychological disorders and physical activity levels should all be reviewed, as diet 
(25.3%), physical activity (21%) and motivational issues (19.7%) were the most 
common reasons among patients with WR [75]. Patients seeking BS often present 
with a range of mental health issues including mood, anxiety, addiction and person-
ality disorders [7, 26]. Diagnosis and management of these conditions may improve 
outcomes following BS. As the patient undergoes psychological, dietary and 
physical activity counselling, it is critical to address the hormonal causes, and any 
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anatomic/post-surgical changes that cause WR. Baseline anatomic studies include 
esophagogastroduodenoscopy or an upper gastrointestinal contrast to evaluate the 
GI tract [76]. These modalities provide essential data about the gastric remnant size, 
size of the gastrojejunal anastomosis, presence of gastro-gastric fistula, and loca-
tion/integrity of the bands. Available treatment options include behavior interven-
tions, WL-approved medications, endoscopic interventions and revision surgery to 
counter some of the factors that resulted in WR.
8.1 Behavioral
Psychological and behavioral factors that have negative impact on long term 
WL outcomes include life stressors that derail weight maintenance and decreased 
adherence to the recommended postoperative diet. This is likely due to lack of 
psychological skills to engage in long term healthy eating behaviors. This is par-
ticulalry important as the effects of surgery on appetite, hunger, and desire for 
food decrease. The aim is to address such challenges by behavioral therapy that is 
tailored to each patient’s need [77, 78]. Many patients with WR are lost to follow up; 
therefore, open, non-judgmental strategies that support the actions that patients are 
doing well are critical to motivate and involve patients in management [76].
A 6-week intervention of cognitive and dialectical behavior therapies among 
29 RYGB patients (93% female) with WR of 37% of the initial WL, found that 
treatment completers had 1.6 ± 2.38 kg mean weight decrease compared with non 
completers [79]. Moreover, patients who completed behavior therapy treatment 
had improvement in their depressive symptoms with decreased grazing patterns 
(p ≤ 0.01), as well as subjective binge eating episodes (p ≤ 0.03) compared to non-
completers [79]. Likewise, a 10-week behavioral intervention of psychological skills 
to mitigate WR among 11 patients after BS was feasible, acceptable (72% reten-
tion), and with high satisfaction among completers (4.25 out of 5.00)[80]. WR was 
stopped or reversed, with a mean 3.58 ± 3.02% total body WL% [80]. Similarly, the 
use of acceptance-based strategies and online or phone intervention delivery modes 
to enhance outcomes and reach more patients showed feasibility, acceptability (70% 
retention), efficacy, high satisfaction score of (4.7 out of 5.0), and reversal of WR 
with a mean 5.1 ± 5.5% total WL% at 3-month follow-up [81].
8.2 Dietary
Structured dietary interventions assist patients to improve WL. A randomized 
controlled trial (RCT) assigned post RYGB patients into two groups: a structured 
dietary intervention incorporating portion-controlled foods vs. a control group [77]. 
Both groups received behavioral WL instructions (one 60-min session followed by 4 
coaching telephone calls at monthly intervals). The intervention group had signifi-
cantly reduced calorie intake at 4 months (−108 vs. 116 Kcal) and increased WL% 
at 4 and 6 months compared to the control group (−4.56% vs. −0.13%, −4.07% vs. 
−0.14%, respectively) [77]. Another 16-week RCT among women who regained ≥5% 
of their lowest post-RYGB weight found that whey protein supplementation pro-
moted WL and fat mass loss, with preserved muscle mass, compared to controls who 
gained weight (0.42 kg) and fat mass [82].
8.3 Pharmacological
Prior to 2012, the only FDA-approved WL drugs were orlistat, a modestly effec-
tive pancreatic lipase inhibitor with some side effects and phentermine, a sympa-
thomimetic appetite suppressant approved for short-term use [83]. Since 2012, 4 
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other WL medications were approved [83]: phentermine-topiramate, bupropion 
hydrochloride-naltrexone hydrochloride, liraglutide and lorcaserin hydrochloride 
(withdrawn due to cancer risk [84]). Since then, anti-obesity medications have 
been increasingly used to manage WR post-BS. In an assessment of anti-obesity 
medications for WR/IWL among 319 patients (258 RYGB, 61 LSG), 54% lost ≥5% 
of their TBW, with many high responders (30.3% of patients lost ≥10%, and 15% 
lost ≥15% of their TBW) [85]. Of the 14 FDA approved and off-label anti-obesity 
medications, only topiramate showed statistically significant WL, where patients 
were 1.9 times more likely to lose ≥10% of their TBW [85]. Regardless of the 
postoperative BMI, RYGB patients were significantly more likely to lose ≥5% of 
their TBW with anti-obesity medications [85]. Another study of individual and 
combined anti-obesity medications for WR post RYGB reported that patients who 
received medications achieved significantly more WL compared to those not using 
anti-obesity medications [86]. Additionally, there was slower overall WR in the 
anti-obesity medications group during long term (11 year) follow up [86].
Among young adults post RYGB and LSG, topiramate, phentermine, and/or 
metformin led to 54.1%, 34.3% and 22.9% of patients losing ≥5% ≥10% and ≥ 15%, 
of their weight respectively [87]. Again, RYGB had higher median WL% than LSG 
(−8.1% vs. −3.3%), with no differences whether the anti-obesity medications were 
started at weight plateau or after WR [87]. In another study, phentermine was 
compered to phentermine–topiramate combination among RYGB or LAGB patients 
with WR and WL plateau [88]. The study showed that phentermine and phenter-
mine–topiramate patients lost 6.35 kg (12.8% EWL%) and 3.81 kg (12.9% EWL%) 
respectively at 90 days post treatment [88].
Liraglutide, a GLP-1 analogue with central and peripheral actions, inhibits 
glucagon secretion, increases insulin secretion, decreases the gastric emptying rate, 
and promotes satiety [89]. In a recently published study, among 117 patients with 
WR after RYGB, LAGB and LSG, the use of liraglutide 3 mg over a 7 month period 
resulted in statistically significant WL (−6.3 ± 7.7 kg, P < .05) compared to baseline 
regardless of the type of surgery [90]. Moreover, the decrease in weight remained 
significant even after one year of liraglutide use [30]. In this study, nausea was the 
most prevalent side effect (29.1% patients) [90].
8.4 Surgical
Revision of a previous BS are carried out due to surgical complications e.g., 
development of intractable marginal ulcer, gastro-gastric fistula, severe gastro-
esophageal reflux, and malnutrition [91]. Recently, revisional surgery is increas-
ingly utilized for the management of WR [91, 92].
8.4.1 After failed LAGB
In patients with WR or IWL after gastric band, the surgical options include 
band removal and revisional BS. A retrospective study evaluated the outcomes of 
revision of LAGB for inadequate weight loss to LSG or single anastomosis duode-
nal switch and found that patients who underwent single anastomosis duodenal 
switch had significantly greater weight loss than LSG in the first year post surgery, 
with excess BMI loss percentage of 66.7% versus 51.5% [93]. In the same study, 
at >12 months post revision, both single anastomosis duodenal switch patients 
and LSG patients had adequate WL (79% for single anastomosis duodenal switch 
versus 67.8% for LSG) [93]. A systematic review compared the WL outcomes of 
conversion gastric band to LSG or RYGB and showed significant increase in EWL% 
in RYGB and patients than LSG patients at 12 and 24 months after revision [94]. 
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However, no statistically significant change was observed in terms of EWL% after 
3, 6, or 36 months post revision [94]. RYGB was also associated with a higher rate of 
 complications, readmission and longer operative time [94].
8.4.2 After failed LSG
Several surgical interventions can be considered for failed LSG including 
conversion to RYGB, biliopancreatic diversion with duodenal switch (BPD/DS), 
one anastomosis gastric bypass (OAGB) or single anastomosis duodeno-ileal bypass 
with sleeve gastrectomy (SADI-S). Among 43 post LSG patients who had revisional 
surgery for IWL/WR (25 patients converted to BPD/DS, 18 to RYGB), the median 
EWL% after 34 months was significantly greater for BPD/DS compared to RYGB 
(59% vs. 23%) [14]. However, short-term complications and vitamin deficiencies 
were higher in BPD/DS compared with RYGB [14].
Conversions of LSG to OAGB or RYGB are also utilized to manage WR. At 
12 months, mean total WL percentage was significantly higher in OAGB compared 
to RYGB (15.8 ± 7.8% vs. 10.3 ± 7.6%), with no differences in readmission and com-
plications between the two procedures, suggesting that OAGB is safe after failed LSG 
[95]. However, long-term follow up including the risk of malnutrition is needed for a 
complete evaluation of OAGB as a revisional BS. Another study evaluating the con-
version of LSG to four different gastric bypass procedures including proximal RYGB, 
type 2 distal RYGB, long biliopancreatic limb RYGB and OAGB showed that the long 
biliopancreatic limb RYGB and OAGB resulted in significant EWL% at 3 years (33.8% 
and 33.2% respectively). However, the effect lasted only for 2 years in the proximal 
RYGB (EWL% of 23.1%) [96].
SADI-S is a relatively new procedure utilized as an alternative to the current 
duodenal switch (DS) [97]. Outcomes of SADI-S as a revision after LSG showed 
20.5% weight loss and 9.4 units BMI change two years post revision with 93.7% 
T2DM remission rate [98]. Additionally, there were no mortality or conversions to 
open surgery, and postoperative early and late complication rates were low (5.3% 
and 6.4% respectively) [98].
8.4.3 After failed RYGB
There seems no standardized approach to revisional surgery after failed RYGB. 
A systemic review of revision of RYGB for WR (799 studies, 866 patients) assessed 
5 revisions: conversion to distal RYGB or BPD/DS, or revision of gastric pouch and 
anastomosis, revision with gastric band or endoluminal procedures [92]. At 3-years 
after revision, mean excess body mass index loss percentage for distal RYGB was 
52.2%, for BPD/DS was 76%, for gastric pouch or anastomosis revision was 14%, 
for gastric banding revision was 47.3%, and for endoluminal procedures was 32.1% 
[92]. Amongst these revisions, gastric pouch or anastomosis revision had the lowest 
rates for major complications (3.5%), while DRYGB had the highest rate for major 
complications (11.9%) and mortality (0.6%) [92]. A recently published study showed 
promising short and long term results as regards to the conversion of RYGB to long 
biliopancreatic limb RYGB for the management of IWL, where patients achieved an 
additional excess EWL% ranging from 40.0% at 1 year to 45.3% at 6 years [99].
9. Conclusions
Although BS is an effective treatment for weight loss and comorbidities resolu-
tion, however WR may occur on the long term. The lack of a standard definition 
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and consensus on what constitutes clinically significance WR leads to poor report-
ing of this entity which requires further research. The underlying factors that 
contribute to WR are multifactorial, including hormonal and surgical causes, 
nutritional noncompliance, physical inactivity, and mental health issues. Therefore, 
patients with significant WR following BS should undergo comprehensive evalua-
tions to determine the underlying etiology. Management should focus on preventive 
and treatment strategies delivered in a multidisciplinary approach to include dietary 
intervention, behavioral counseling, lifestyle modifications, pharmacotherapy 
and, if indicated, surgical revision. Future research should focus to identify the 
 etiological factors and effective intervention strategies.
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